Chapter 9 – Molecular Imaging to Identify the Vulnerable Plaque: From Basic Research to Clinical Practice*

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1016/B978-0-12-800039-7.00009-8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Is there a role for coronary angiography in the early detection of the vulnerable plaque?

  2013cited by this paper
• Associations of reactive hyperemia index and intravascular ultrasound-assessed coronary plaque morphology in patients with coronary artery disease.

  2012cited by this paper
• Correlation between arterial FDG uptake and biomarkers in peripheral artery disease.

  2012cited by this paper
• Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography.

  2012cited by this paper
• Apoptotic cell death and efferocytosis in atherosclerosis.

  2012cited by this paper
• Development of a Magnetic Resonance Imaging Protocol for the Characterization of Atherosclerotic Plaque by Using Vascular Cell Adhesion Molecule-1 and Apoptosis-Targeted Ultrasmall Superparamagnetic Iron Oxide Derivatives

  2012cited by this paper
• Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.

  2012cited by this paper
• Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

  2012cited by this paper
• Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis

  2012cited by this paper
• In vivo assessment of intraplaque and endothelial fibrin in ApoE(-/-) mice by molecular MRI.

  2012cited by this paper
• Inflammatory markers and plaque morphology: an optical coherence tomography study.

  2012cited by this paper
• Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody.

  2012cited by this paper
• The growing interest of fibrin imaging in atherosclerosis.

  2012cited by this paper
• Different stages of intraplaque hemorrhage are associated with different plaque phenotypes: a large histopathological study in 794 carotid and 276 femoral endarterectomy specimens.

  2011cited by this paper
• Positron emission tomography for benign and malignant disease.

  2011cited by this paper
• MRI of inducible P‐selectin expression in human activated platelets involved in the early stages of atherosclerosis

  2011cited by this paper
• Progress and challenges in translating the biology of atherosclerosis

  2011cited by this paper
• Radiolabeled Fucoidan as a P-Selectin Targeting Agent for In Vivo Imaging of Platelet-Rich Thrombus and Endothelial Activation

  2011cited by this paper
• Macrophages in the pathogenesis of atherosclerosis.

  2011cited by this paper
• Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases.

  2011cited by this paper
• Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinases.

  2011cited by this paper
• Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.

  2011cited by this paper
• Pulling down the plug on atherosclerosis: Finding the culprit in your heart

  2011cited by this paper
• Investigating Vulnerable Atheroma Using Combined 18F-FDG PET/CT Angiography of Carotid Plaque with Immunohistochemical Validation

  2011cited by this paper
• Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography.

  2011cited by this paper
• The hemostatic system as a modulator of atherosclerosis.

  2011cited by this paper
• Feasibility of 18F-Sodium Fluoride PET/CT for Imaging of Atherosclerotic Plaque

  2010cited by this paper
• Imaging Atherosclerosis and Vulnerable Plaque

  2010cited by this paper
• Biodistribution of 99mTc-HYNIC-lactadherin in mice – a potential tracer for visualizing apoptosis in vivo

  2010cited by this paper
• Molecular Imaging of Atherosclerotic Plaques Targeted to Oxidized LDL Receptor LOX-1 by SPECT/CT and Magnetic Resonance

  2010cited by this paper
• Immunolocalisation of fibrin in coronary atherosclerosis: implications for necrotic core development

  2010cited by this paper
• Phosphatidylserine targeting for diagnosis and treatment of human diseases

  2010cited by this paper
• Macrophage death and defective inflammation resolution in atherosclerosis

  2010cited by this paper
• Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time?

  2010cited by this paper
• Comparison of the C2A domain of synaptotagmin-I and annexin-V as probes for detecting cell death.

  2010cited by this paper
• Life and death in the atherosclerotic plaque

  2010cited by this paper
• Targeting very small model lesions pretargeted with bispecific antibody with 99mTc-labeled high-specific radioactivity polymers

  2010cited by this paper
• In Vivo Evaluation of a New Magnetic Resonance Imaging Contrast Agent (P947) to Target Matrix Metalloproteinases in Expanding Experimental Abdominal Aortic Aneurysms

  2010cited by this paper
• Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography.

  2010cited by this paper
• Molecular imaging of inflammation and intraplaque vasa vasorum: A step forward to identification of vulnerable plaques?

  2010cited by this paper
• Macrophage Apoptosis in Atherosclerosis: Consequences on Plaque Progression and the Role of Endoplasmic Reticulum Stress

  2009cited by this paper
• Impact of vascular remodeling on the coronary plaque compositions: an investigation with in vivo tissue characterization using integrated backscatter-intravascular ultrasound.

  2009cited by this paper
• Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide

  2009cited by this paper
• Atherosclerotic Carotid Vulnerable Plaque and Subsequent Stroke: A High-Resolution MRI Study

  2009cited by this paper
• Controversies in cardiovascular medicine series Imaging of the unstable plaque : how far have we got ?

  2009cited by this paper
• Macrophage-specific lipid-based nanoparticles improve cardiac magnetic resonance detection and characterization of human atherosclerosis.

  2009cited by this paper
• Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.

  2009cited by this paper
• Noninvasive monitoring of myocardial angiogenesis

  2009cited by this paper
• Imaging of Inflamed and Vulnerable Plaque in Coronary Arteries with 18F-FDG PET/CT in Patients with Suppression of Myocardial Uptake Using a Low-Carbohydrate, High-Fat Preparation

  2009cited by this paper
• Molecular Imaging of Matrix Metalloproteinase Expression in Atherosclerotic Plaques of Mice Deficient in Apolipoprotein E or Low-Density-Lipoprotein Receptor

  2009cited by this paper
• Relationships Among Regional Arterial Inflammation, Calcification, Risk Factors, and Biomarkers: A Prospective Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Imaging Study

  2009cited by this paper
• Vascular Inflammation Imaging with 18F-FDG PET/CT: When to Image?

  2009cited by this paper
• Assessment of claims of improved prediction beyond the Framingham risk score.

  2009cited by this paper
• PET and SPECT imaging of apoptosis in vulnerable atherosclerotic plaques with radiolabeled Annexin A5.

  2009cited by this paper
• Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo.

  2009cited by this paper
• Mechanisms and consequences of efferocytosis in advanced atherosclerosis

  2009cited by this paper
• Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events

  2008cited by this paper
• Evaluation of Matrix Metalloproteinases in Atherosclerosis Using a Novel Noninvasive Imaging Approach

  2008cited by this paper
• MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients

  2008cited by this paper
• Targeting of Lectinlike Oxidized Low-Density Lipoprotein Receptor 1 (LOX-1) with 99mTc-Labeled Anti–LOX-1 Antibody: Potential Agent for Imaging of Vulnerable Plaque

  2008cited by this paper
• Micro-CT based analysis of a new paradigm for vulnerable plaque rupture: cellular microcalcifications in fibrous caps.

  2008cited by this paper
• Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.

  2008cited by this paper
• Annexin A5: an imaging biomarker of cardiovascular risk

  2008cited by this paper
• Imaging of atherosclerotic cardiovascular disease

  2008cited by this paper
• Detection of cell death in tumors by using MR imaging and a gadolinium-based targeted contrast agent.

  2008cited by this paper
• Magnetic Resonance Imaging of Endothelial Adhesion Molecules in Mouse Atherosclerosis Using Dual-Targeted Microparticles of Iron Oxide

  2007cited by this paper
• Osteogenesis Associates With Inflammation in Early-Stage Atherosclerosis Evaluated by Molecular Imaging In Vivo

  2007cited by this paper
• Data Supplement (unedited) at:

  2007cited by this paper
• (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.

  2007cited by this paper
• Molecular MR Imaging of Human Thrombi in a Swine Model of Pulmonary Embolism Using a Fibrin-Specific Contrast Agent

  2007cited by this paper
• Acute coronary syndromes in Europe: 1-year costs and outcomes

  2007cited by this paper
• Angiogenesis in atherosclerosis: gathering evidence beyond speculation

  2006cited by this paper
• Inflammation in Atherosclerosis: Visualizing Matrix Metalloproteinase Action in Macrophages In Vivo

  2006cited by this paper
• Multiple biomarkers for the prediction of first major cardiovascular events and death.

  2006cited by this paper
• 5-pyrrolidinylsulfonyl isatins as a potential tool for the molecular imaging of caspases in apoptosis.

  2006cited by this paper
• Identifying Inflamed Carotid Plaques Using In Vivo USPIO-Enhanced MR Imaging to Label Plaque Macrophages

  2006cited by this paper
• Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis.

  2006cited by this paper
• Pathology of the Vulnerable Plaque

  2006cited by this paper
• Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification

  2006cited by this paper
• From Vulnerable Plaque to Vulnerable Patient—Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report

  2006cited by this paper
• Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study.

  2006cited by this paper
• A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps

  2006cited by this paper
• In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.

  2006cited by this paper
• PET of vascular endothelial growth factor receptor expression.

  2006cited by this paper
• The role of shear stress in the generation of rupture-prone vulnerable plaques

  2005cited by this paper
• Molecular Magnetic Resonance Imaging of Coronary Thrombosis and Pulmonary Emboli With a Novel Fibrin-Targeted Contrast Agent

  2005cited by this paper
• Inflammation, atherosclerosis, and coronary artery disease.

  2005cited by this paper
• Phagocytosis of Apoptotic Cells by Macrophages Is Impaired in Atherosclerosis

  2005cited by this paper
• MRI plaque tissue characterization and assessment of plaque stability.

  2005cited by this paper
• Association of vascular 18F-FDG uptake with vascular calcification.

  2005cited by this paper
• Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries

  2005cited by this paper
• Proportion of fibrin and platelets differs in thrombi on ruptured and eroded coronary atherosclerotic plaques in humans

  2005cited by this paper
• Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99mTc-Annexin V, 18F-FDG, and histologic evaluation.

  2005cited by this paper
• Smooth muscle cell proliferation index correlates with 111In-labeled antibody Z2D3 uptake in a transplant vasculopathy swine model.

  2005cited by this paper
• Impaired Clearance of Apoptotic Cells Promotes Synergy between Atherogenesis and Autoimmune Disease

  2004cited by this paper
• Spotty Calcification Typifies the Culprit Plaque in Patients With Acute Myocardial Infarction: An Intravascular Ultrasound Study

  2004cited by this paper
• In Vivo Magnetic Resonance Imaging of Coronary Thrombosis Using a Fibrin-Binding Molecular Magnetic Resonance Contrast Agent

  2004cited by this paper
• Molecular Imaging of Atherosclerotic Plaques Using a Human Antibody Against the Extra-Domain B of Fibronectin

  2004cited by this paper
• Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis.

  2004cited by this paper
• Detection of cardiomyocyte death in a rat model of ischemia and reperfusion using 99mTc-labeled annexin V.

  2004cited by this paper

• No citing papers are available for this paper.